17 Aug 2016
Pharmac called on to improve funding practices
Melanoma sufferers who missed out on Keytruda, now funded by Pharmac, are still paying the price, a parliamentary select committee has been told.
Show status: Off air
Recent stories from Checkpoint
Get the RNZ app
for easy access to all your favourite programmes
